NFKB1 and pneumonia: A recent mechanistic investigation revealed that SHNG16 acts as a ceRNA to positively regulate Toll-like receptor 4 (TLR4) and thus affect the LPS-induced inflammatory and immune processes via mediating JNK and NF-κB pathways in pneumonia (Zhou et al., 2019).